whether Lantus increases cancer risk
August 2009
Patients are asking whether Lantus increases cancer risk.
Recent European studies suggest a higher cancer risk in patients using Lantus (insulin glargine) ALONE compared to other insulins.
A Swedish study suggests one extra case of breast cancer for every 1000 women using Lantus alone for 1 year compared to other insulins.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote